Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Photon-counting CT versus traditional CT for suspected coronary artery disease

Official title: Randomized Prospective Trial on the Cost-Effectiveness of Photon-Counting CT Versus Energy-Integrating Detector CT in Suspected Chronic Coronary Syndrome

Run by IRCCS San Raffaele · NCT07831304 · Data updated 2026-11-12

This trial tests whether photon-counting CT can better diagnose obstructive CAD in people who need a coronary CTA than the standard energy-integrating detector CT.

More Coronary Artery Disease trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment630 (estimated)
SponsorIRCCS San Raffaele
Academic / other
Locations1 site (Milan, Milano)
StatusRecruiting
StartedSeptember 1, 2026
Main results expectedSeptember 30, 2027
Study endsSeptember 30, 2029
Registry record updatedNovember 6, 2026
Trial IDNCT07831304 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults needing CCTA for suspected obstructive CAD, without severe kidney impairment, and willing to participate.

Probably not a fit

Patients with no diagnostic advantage from imaging modality differences or those with contraindications to CCTA may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized interventional trial compares two CT imaging technologies for evaluating suspected CAD. Participants with a clinical indication for CCTA are assigned to undergo CCTA with either photon-counting CT or conventional energy-integrating detector CT. The goal is to see if the photon-counting approach improves diagnostic accuracy and reduces unnecessary downstream testing or invasive procedures. The study focuses on how improved image quality and reduced artifacts may affect stenosis classification and subsequent treatment decisions. The trial is conducted at a Milan-based imaging center, led by IRCCS San Raffaele, with eligibility limited to adults without severe renal impairment who meet current ESC guidelines.

Why it matters

Potential benefit: If successful, patients may receive more accurate CAD diagnoses with fewer false positives and unnecessary follow-up tests.

How similar studies have gone: Previous work suggests photon-counting CT can reduce blooming artifacts and improve diagnostic accuracy in cardiac imaging, but this specific head-to-head trial in CAD is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* clinical indication to perform CCTA for CAD assessment according to 2024 ESC Guidelines

Exclusion Criteria:

* Refusal to participate in the study
* Age \<18 years old
* Severe reduction in eGFR (\<30 mL/min)

Where it's running

  • Advanced Imaging for Personalized Medicine/Radiologia DiMer
    Milan, Milano, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.